tophi Recommendations for patients receiving ULT medications Allopurinol The HLA-B*5801 allele is associated with a markedly elevated risk for AHS 3 Recommendation PICO question Certainty of evidence For all patients taking ULT, we strongly recommend a treat-to-target strategy of ULT dose management that includes dose titration and subsequent dosing guided by serial SU values to achieve an SU target over a fixed, standard-dose ULT strategy. Moderate For all patients taking ULT, we strongly